Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Noncash or Part Noncash Acquisition, Fixed Assets Acquired

AIM IMMUNOTECH INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired

AIM IMMUNOTECH INC. (AIM) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2014-03-14

  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2011-12-31 was $0.00.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2011-06-30 was $36.00K.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2011-03-31 was $26.00K.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2013 was $0.00.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2011 was $62.00K, a 69.00% decline from fiscal 2010.
  • AIM IMMUNOTECH INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2010 was $200.00K.
Period endNoncash or Part Noncash Acquisition, Fixed Assets Acquired 3 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 6 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 9 monthNoncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month
2013-12-31$0.00
10-K · filed 2014-03-14
2012-12-31$0.00
10-K · filed 2014-03-14
2012-06-30$0.00
10-Q · filed 2012-08-08
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$0.00
derived: sum of 2 quarters · filed 2014-03-14
$36.00K
derived: sum of 3 quarters · filed 2014-03-14
$62.00K
10-K · filed 2014-03-14
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02
$36.00K
derived: sum of 2 quarters · filed 2012-11-02
$62.00K
10-Q · filed 2012-11-02
$62.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$36.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$62.00K
10-Q · filed 2012-08-08
$62.00K
derived: sum of 3 quarters · filed 2013-03-18
$192.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$26.00K
10-Q · filed 2012-05-07
$26.00K
derived: sum of 2 quarters · filed 2013-03-18
$156.00K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$130.00K
derived: sum of 2 quarters · filed 2013-03-18
$200.00K
10-K · filed 2013-03-18
2010-09-30$130.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$200.00K
10-Q · filed 2011-11-09
2010-06-30$70.00K
10-Q · filed 2011-08-05
2009-12-31$0.00
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B